Natural history of acute HCV infection in hemodialysis patients

M Espinosa1, A Martin-Malo, M A Alvarez de Lara

  • 1Servicios de Nefrologia, Hospital Universitario Reina Sofia, Cordoba, Spain. espinosahe@supercable.com

Clinical Nephrology
|September 14, 2002
PubMed

Insights

Hepatitis C virus (HCV) infection frequently leads to chronic liver disease in hemodialysis patients. Over half of acute cases progressed to chronic hepatopathy, though some patients achieved spontaneous HCV clearance.

Area of Science:

  • Hepatology
  • Virology
  • Nephrology

Background:

  • Hepatitis C virus (HCV) infection is a significant concern in hemodialysis patients, often leading to chronic liver disease.
  • Understanding the progression of acute HCV to chronic hepatopathy in this vulnerable population is crucial for patient management.

Purpose of the Study:

  • To analyze the long-term outcomes of acute hepatitis C in hemodialysis patients.
  • To determine the rate of evolution to chronic liver disease and identify risk factors.

Main Methods:

  • A prospective follow-up study of 19 hemodialysis patients with acute hepatitis C was conducted over 11 years.
  • Patients were monitored monthly for alanine aminotransferase (ALT) and HCV-RNA.
  • Evolution to chronic liver disease was assessed using biochemical and virological markers.

Main Results:

  • The majority of patients (78.9%) developed chronic viremia, and 57.8% progressed to chronic liver disease within a median follow-up of 3 years.
  • Liver biopsies in five patients revealed histologic signs of chronic active hepatitis, with one progressing to cirrhosis.
  • HCV infection resolved spontaneously in 21% of patients; however, mortality was high (36.8%) though not directly linked to acute HCV as an independent risk factor.

Conclusions:

  • A significant proportion of hemodialysis patients with acute hepatitis C develop chronic liver disease, with 56.2% progressing within three years.
  • Spontaneous clearance of HCV infection occurred in 21% of cases, highlighting variability in disease outcomes.
  • Close monitoring and management strategies are essential for hemodialysis patients with HCV infection to mitigate long-term complications.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...